Radcliffe Capital Management’s Turmeric Acquisition Corp. Class A Ordinary Shares TMPM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-215,470
Closed -$2.15M 1184
2022
Q3
$2.15M Hold
215,470
0.05% 606
2022
Q2
$2.14M Buy
215,470
+35,798
+20% +$354K 0.05% 640
2022
Q1
$1.77M Buy
179,672
+600
+0.3% +$5.9K 0.04% 712
2021
Q4
$1.76M Hold
179,072
0.05% 620
2021
Q3
$1.75M Hold
179,072
0.05% 518
2021
Q2
$1.77M Buy
179,072
+72,230
+68% +$710K 0.06% 544
2021
Q1
$1.04M Buy
+106,842
New +$1.09M 0.04% 562

Radcliffe Capital Management's TMPM Position: Q4 2022 in Review

Radcliffe Capital Management sold out of Turmeric Acquisition Corp. Class A Ordinary Shares (TMPM) in Q4 2022, closing a stake of 215,470 shares — an estimated $2.15M sold.

Radcliffe Capital Management first reported a position in TMPM in Q1 2021 and held it in 7 quarters. The position peaked at $2.15M in Q3 2022. 0 funds tracked by Wall St. Rank hold TMPM as of Q4 2022.

  • Radcliffe Capital Management reported no remaining Turmeric Acquisition Corp. Class A Ordinary Shares position as of Q4 2022 after selling out during the quarter.
  • Radcliffe Capital Management sold 215,470 Turmeric Acquisition Corp. Class A Ordinary Shares shares in Q4 2022, an estimated $2.15M.
  • Radcliffe Capital Management first reported a position in Turmeric Acquisition Corp. Class A Ordinary Shares in Q1 2021 and held it in 7 quarters.
  • Radcliffe Capital Management's Turmeric Acquisition Corp. Class A Ordinary Shares position peaked at $2.15M in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Turmeric Acquisition Corp. Class A Ordinary Shares as of Q4 2022.

Based on Radcliffe Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.